Atlas Trials

Irinotecan and Cediranib in Treating Patients With Metastatic Colorectal Cancer That Did Not Respond to Previous Oxaliplatin, Fluoropyrimidine, and Bevacizumab

Clinical trial NCT00588900 · TERMINATED

Trial details

NCT number
NCT00588900
Sponsor
Alliance for Clinical Trials in Oncology
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Colorectal Cancer
Start date
2008-03-01
Primary completion
2010-05-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.